BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12745664)

  • 1. Beta-cell expansion for therapeutic compensation of insulin resistance in type 2 diabetes.
    Efrat S
    Int J Exp Diabesity Res; 2003; 4(1):1-5. PubMed ID: 12745664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of islet amyloid in type 2 diabetes mellitus.
    Höppener JW; Lips CJ
    Int J Biochem Cell Biol; 2006; 38(5-6):726-36. PubMed ID: 16459127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-cell deficit due to increased apoptosis in the human islet amyloid polypeptide transgenic (HIP) rat recapitulates the metabolic defects present in type 2 diabetes.
    Matveyenko AV; Butler PC
    Diabetes; 2006 Jul; 55(7):2106-14. PubMed ID: 16804082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms linking obesity to insulin resistance and type 2 diabetes.
    Kahn SE; Hull RL; Utzschneider KM
    Nature; 2006 Dec; 444(7121):840-6. PubMed ID: 17167471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features of insulin resistance and beta cell dysfunction and the relationship to type 2 diabetes.
    Stumvoll M; Gerich J
    Clin Lab Med; 2001 Mar; 21(1):31-51. PubMed ID: 11321936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive beta cell failure in type 2 diabetes mellitus of youth.
    Gungor N; Arslanian S
    J Pediatr; 2004 May; 144(5):656-9. PubMed ID: 15127006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoring a functional beta-cell mass in diabetes.
    Pipeleers D; Chintinne M; Denys B; Martens G; Keymeulen B; Gorus F
    Diabetes Obes Metab; 2008 Nov; 10 Suppl 4():54-62. PubMed ID: 18834433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nature history and genetics of type 2 diabetes].
    Ji LN
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Oct; 24(5):512-8. PubMed ID: 12905776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-cell deficiency, insulin resistance, or both?
    Cahill GF
    N Engl J Med; 1988 May; 318(19):1268-70. PubMed ID: 3283556
    [No Abstract]   [Full Text] [Related]  

  • 10. The vascular trigger of type II diabetes mellitus.
    Lammert E
    Exp Clin Endocrinol Diabetes; 2008 Sep; 116 Suppl 1():S21-5. PubMed ID: 18777448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non-insulin dependent diabetes: beta-cell failure or insulin resistance, an unsolved controversy].
    Herrera Pombo JL
    Rev Clin Esp; 1991 Apr; 188(7):329-31. PubMed ID: 1784759
    [No Abstract]   [Full Text] [Related]  

  • 12. Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance.
    Polonsky KS; Sturis J; Bell GI
    N Engl J Med; 1996 Mar; 334(12):777-83. PubMed ID: 8592553
    [No Abstract]   [Full Text] [Related]  

  • 13. Functional pancreatic beta-cell mass: involvement in type 2 diabetes and therapeutic intervention.
    Karaca M; Magnan C; Kargar C
    Diabetes Metab; 2009 Apr; 35(2):77-84. PubMed ID: 19251449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. beta-cell function and anti-diabetic pharmacotherapy.
    Del Prato S; Bianchi C; Marchetti P
    Diabetes Metab Res Rev; 2007 Oct; 23(7):518-27. PubMed ID: 17883249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance: from benign to type 2 diabetes mellitus.
    Goldstein BJ
    Rev Cardiovasc Med; 2003; 4 Suppl 6():S3-10. PubMed ID: 14668698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equivalent insulin resistance in latent autoimmune diabetes in adults (LADA) and type 2 diabetic patients.
    Chiu HK; Tsai EC; Juneja R; Stoever J; Brooks-Worrell B; Goel A; Palmer JP
    Diabetes Res Clin Pract; 2007 Aug; 77(2):237-44. PubMed ID: 17234296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of oxidative stress, endoplasmic reticulum stress, and c-Jun N-terminal kinase in pancreatic beta-cell dysfunction and insulin resistance.
    Kaneto H; Nakatani Y; Kawamori D; Miyatsuka T; Matsuoka TA; Matsuhisa M; Yamasaki Y
    Int J Biochem Cell Biol; 2005 Aug; 37(8):1595-608. PubMed ID: 15878838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell therapy for type 2 diabetes: is it desirable and can we get it?
    Halban PA
    Diabetes Obes Metab; 2008 Nov; 10 Suppl 4():205-11. PubMed ID: 18834449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 2 diabetes-a matter of beta-cell life and death?
    Rhodes CJ
    Science; 2005 Jan; 307(5708):380-4. PubMed ID: 15662003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic islet inflammation in type 2 diabetes: from alpha and beta cell compensation to dysfunction.
    Ehses JA; Ellingsgaard H; Böni-Schnetzler M; Donath MY
    Arch Physiol Biochem; 2009 Oct; 115(4):240-7. PubMed ID: 19645635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.